As more seniors embrace active post-retirement lifestyles, a possibly serious health threat is gaining increased attention from medical professionals. Respiratory Syncytial Virus, or RSV, long considered a childhood illness, is now recognized as a significant risk for older adults, contributing to hospitalizations and even fatalities. geriatric specialist dr. Raymond Lo warns that RSV can have a particularly devastating impact on those with underlying health conditions, and emphasizes the importance of awareness and preventative measures as the virus circulates within communities.
As parents enjoy their well-deserved retirement, traveling and embracing a more relaxed lifestyle, it’s crucial to be aware of a “silent killer” lurking in crowded spaces like airplanes and popular tourist destinations. According to geriatric specialist Dr. Raymond Lo, respiratory syncytial virus (RSV) is a common and highly contagious respiratory virus that can cause severe complications, hospitalization, and even death in older adults. Data indicates that approximately 6% to 8% of older adults hospitalized with RSV die during their hospital stay, making it a significant cause of mortality among this population.
Older Adults with Chronic Conditions Face Doubled Risk
The body’s organ function and immune system naturally decline with age, making older adults more susceptible to chronic diseases such as chronic bronchitis, heart failure, and diabetes. This vulnerability is particularly concerning when it comes to RSV, as those with pre-existing chronic conditions are at even higher risk of hospitalization. For example, individuals with heart failure are 4 to 33.2 times more likely to be hospitalized with RSV compared to those without the condition. Beyond increased hospitalization and oxygen use, patients are also more likely to require intensive care unit admission.
“The impact of RSV on older adults is just as significant as that of influenza,” Dr. Lo emphasized. “Older adults infected with RSV have a higher risk of developing pneumonia, and their risk of death within one year of hospitalization is notably increased.” He recommends seeking prompt medical attention or utilizing rapid antigen testing upon experiencing related symptoms to enable early diagnosis and treatment, thereby reducing the likelihood of severe complications.
RSV’s Impact May Be Irreversible
The concerning aspect of RSV lies in the potential for long-lasting damage to the body. Dr. Lo shared the case of a 90-year-old woman with heart disease, hypertension, and dementia who required significant daily care. She was hospitalized for breathing difficulties and tested positive for both influenza and RSV. With no specific antiviral medications currently available for RSV, treatment focused on supportive care to alleviate symptoms. While her symptoms eventually subsided, the woman’s overall condition deteriorated, and she became reliant on a feeding tube. Dr. Lo explained that this decline was likely a result of a cascade of effects triggered by the viral infection, accelerating cognitive decline and leading to a downward spiral in her health.
To prevent such outcomes, vaccination is key. Currently, two RSV vaccines are available, with a bivalent vaccine recommended for pregnant women between 32 and 36 weeks of gestation and adults aged 60 and older. Vaccination during pregnancy provides comprehensive protection for newborns. Older adults should undergo a health assessment and discuss the most appropriate vaccine option with their physician. Dr. Lo also cautioned against complete social isolation to reduce infection risk, as this can negatively impact mental health and overall quality of life.
Information provided by Dr. Raymond Lo
Geriatric specialist Dr. Raymond Lo
